Newscast – Page 173 – media

GlaxoSmithKline taking heat in its U.K. home turf over shortages of hepatitis B vaccine

GlaxoSmithKline is taking some heat at home over questions about global shortages of its and Merck’s hepatitis B vaccine that triggered rationing in the U.K., although GSK’s supplies to the much larger U.S. market seem to be unaffected.
- Source: fiercepharma
- 596
- August 24, 2017
hepatitis Market Views vaccine
Siemens gets CE-Mark for MR scanner Magnetom Terra

Siemens Healthineers has received CE-Mark for its ultra-high-field 7T magnetic resonance (MR) scanner Magnetom Terra, making it available for neurological and musculoskeletal clinical examinations in Europe.
- Source: medicaldevice
- 550
- August 24, 2017
Clinical MR musculoskeletal neurological
Cel-Sci raises $3.5m for head and neck cancer immunotherapy

Cel-Sci said today that for a Phase III trial of its investigational immunotherapy, it inked an agreement with institutional investors for a $3.5 million registered direct offering.
- Source: drugdeliverybusiness
- 537
- August 24, 2017
Clinical Trials Company Insight immunotherapy
New flu vaccine approved for UK use

The adjuvanted trivalent influenza vaccine Fluad for use in people aged 65 years or older has been cleared by the Medicines and Healthcare products Regulatory Agency.
- Source: pharmatimes
- 684
- August 23, 2017
influenza New Approvals trivalent vaccine
Biotronik’s tiny, MRI-safe CRT pacemaker secures FDA approval

Biotronik has secured approval from the US Food and Drug Admini(FDA) for its Edora HF-T QP, a MR conditional quadripolar (QP) cardiac resynchronization therapy pacemaker (CRT-P).
- Source: medicaldevices
- 549
- August 23, 2017
cardiac Company Insight New Approvals QP
FDA approves Malin’s Hourglass peripheral embolization plug

FDA has cleared Irish life sciences company Malin Corp for its Hourglass peripheral embolization plug.
- Source: massdevice
- 567
- August 23, 2017
Company Insight embolization FDA New Approvals peripheral
Cynvenio Biosystems initiates breast cancer monitoring study in US

Cynvenio Biosystems has initiated a clinical study to evaluate its LiquidBiopsy ClearID test in combination with NK Score natural killer cell activity to monitor breast cancer patients in the US.
- Source: medicaldevice-network
- 570
- August 22, 2017
breast cancer Clinical Researches
AstraZeneca announces new mRNA collaboration

A five-year strategic research collaboration between AstraZeneca and its global biologics research and development arm MedImmune and Ethris, a company focussed on mRNA-based therapeutics with specific expertise in pulmonary disease.
- Source: pharmatimes
- 824
- August 22, 2017
asthma chronic collaboration Company Insight mRNA therapy
J&J’s Ethicon launches ProxiSure laparoscopic suturing device

The ProxiSure laparoscopic suturing device was launched, said Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon.
- Source: massdevice
- 526
- August 22, 2017
Company Insight FDA laparoscopic suturing
US regulators wave through Pfizer’s leukaemia drug

Pfizer’s Besponsa has been approved by the US Food and Drug Administration (FDA). It's the first and only CD22-directed antibody-drug conjugate indicated to treat relapsed or refractory B-cell precursor acute lymphoblastic leukaemia (ALL).
- Source: pharmatimes
- 1,065
- August 21, 2017
ALL antibody Company Insight FDA New Approvals

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.